Evidence map›Paper›PMID 39197876›Full record

ReviewBasic & clinical pharmacology & toxicology2024

Phenibut: A drug with one too many "buts".

Bill J Gurley, Igor Koturbash

Abstract readReview
In one paragraph

Review in Basic & clinical pharmacology & toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bill J GurleyNational Center for Natural Products Research, University of Mississippi, University, MS, USA.
Igor KoturbashCenter for Dietary Supplements Research, University of Arkansas for Medical Sciences, Little Rock, AR, USA.ORCID https://orcid.org/0000-0002-4090-7008

Funding

The Role of the Mitochondrion in the Metabolic Stress Response to Burn TraumaP20GM109096 · NIGMS · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI BORSHEIM, ELISABET · 2016 to 2025
$20.7M
Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
Arkansas Center for Clinical Translational ResearchKL2TR000063 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$459k
Arkansas Biosciences InstituteClinical and Translational Science Awards KL2TR000063Clinical and Translational Science Awards UL1TR000039NCATS NIH HHS KL2 TR000063NCATS NIH HHS UL1 TR000039NIGMS NIH HHS P20 GM109096NIH HHS P20GM109096
6 · The paper itself

Abstract

Phenibut is a gamma aminobutyric acid derivative with activity at γ-aminobutyric acid (GABA)

Indexed as

gamma-Aminobutyric AcidAnimalsHumansNootropic AgentsSubstance-Related DisordersSubstance Withdrawal Syndrome4-amino-3-phenylbutyric acidgamma-Aminobutyric AcidNootropic Agentsfocused reviewintoxicationphenibutwithdrawalγ‐Aminobutyric acid

Identifiers

PMID39197876
PMCPMC11583343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.